Evaluation of Optimal Treatment Duration of Bevacizumab Combination With Standard Chemotherapy in Patients With Ovarian Cancer (BOOST)
Trial Number
NCT01462890Contact Person
Status
Completed
Disease Site
Ovarian
Lead Cooperative Group
Participating Groups
GINECO
NSGO-CTU